Literature DB >> 15857122

A bioavailability score.

Yvonne C Martin1.   

Abstract

Responding to a demonstrated need for scientists to forecast the permeability and bioavailability (F) properties of compounds before their purchase, synthesis, or advanced testing, we have developed a score that assigns the probability that a compound will have F > 10% in the rat. Neither the rule-of-five, log P, log D, nor the combination of the number of rotatable bonds and polar surface area successfully categorized compounds. Instead, different properties govern the bioavailability of compounds depending on their predominant charge at biological pH. The fraction of anions with >10% F falls from 85% if the polar surface area (PSA) is < or = 75 A(2), to 56% if 75 < PSA < 150 A(2), to 11% if PSA is > or = 150 A(2). On the other hand, whereas 55% of the neutral, zwitterionic, or cationic compounds that pass the rule-of-five have >10% F, only 17% of those that fail have > 10% F. This same categorization distinguishes compounds that are poorly permeable from those that are permeable in Caco-2 cells. Further validation is provided with human bioavailability values from the literature.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857122     DOI: 10.1021/jm0492002

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  90 in total

1.  Successful identification of key chemical structure modifications that lead to improved ADME profiles.

Authors:  Lourdes Cucurull-Sanchez
Journal:  J Comput Aided Mol Des       Date:  2010-05-09       Impact factor: 3.686

2.  Tuberculosis: finding a new potential antimycobacterium derivative in a aldehyde-arylhydrazone-oxoquinoline series.

Authors:  Fernanda da C Santos; Helena C Castro; Maria Cristina S Lourenço; Paula A Abreu; Pedro N Batalha; Anna C Cunha; Guilherme S L Carvalho; Carlos R Rodrigues; Cid A Medeiros; Simone D Souza; Vitor F Ferreira; Maria C B V de Souza
Journal:  Curr Microbiol       Date:  2012-07-08       Impact factor: 2.188

Review 3.  Screening in a spirit haunted world.

Authors:  Brian K Shoichet
Journal:  Drug Discov Today       Date:  2006-07       Impact factor: 7.851

Review 4.  Recent progress in the computational prediction of aqueous solubility and absorption.

Authors:  Stephen R Johnson; Weifan Zheng
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

5.  Molecular mobility, thermodynamics and stability of griseofulvin's ultraviscous and glassy states from dynamic heat capacity.

Authors:  E Tombari; S Presto; G P Johari; Ravi M Shanker
Journal:  Pharm Res       Date:  2007-09-27       Impact factor: 4.200

Review 6.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

7.  Development of an ex vivo lymph node explant model for identification of novel molecules active against Leishmania major.

Authors:  Alex G Peniche; Yaneth Osorio; Adam R Renslo; Doug E Frantz; Peter C Melby; Bruno L Travi
Journal:  Antimicrob Agents Chemother       Date:  2013-10-14       Impact factor: 5.191

8.  An integrated drug-likeness study for bicyclic privileged structures: from physicochemical properties to in vitro ADME properties.

Authors:  Chunyan Han; Jinlan Zhang; Mingyue Zheng; Yao Xiao; Yan Li; Gang Liu
Journal:  Mol Divers       Date:  2011-05-03       Impact factor: 2.943

9.  Inhibitors of SARS-3CLpro: virtual screening, biological evaluation, and molecular dynamics simulation studies.

Authors:  Prasenjit Mukherjee; Falgun Shah; Prashant Desai; Mitchell Avery
Journal:  J Chem Inf Model       Date:  2011-05-23       Impact factor: 4.956

Review 10.  The significance of acid/base properties in drug discovery.

Authors:  David T Manallack; Richard J Prankerd; Elizabeth Yuriev; Tudor I Oprea; David K Chalmers
Journal:  Chem Soc Rev       Date:  2013-01-21       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.